Back to Browse Journals » Vascular Health and Risk Management » Volume 7

Pre-eclampsia: pathophysiology, diagnosis, and management

Authors Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J-M

Published 19 July 2011 Volume 2011:7 Pages 467—474


Review by Single-blind

Peer reviewer comments 3

Jennifer Uzan1, Marie Carbonnel1, Olivier Piconne1,3, Roland Asmar2, Jean-Marc Ayoubi1
1Department of Gynecology and Obstetrics, Hôpital Foch, Suresnes, France; 2Foundation Medical Research Institutes, Geneva, Switzerland; 3Department of Gynecology and Obstetrics, Hôpital Antoine Béclère, Clamart, France

Abstract: The incidence of pre-eclampsia ranges from 3% to 7% for nulliparas and 1% to 3% for multiparas. Pre-eclampsia is a major cause of maternal mortality and morbidity, preterm birth, perinatal death, and intrauterine growth restriction. Unfortunately, the pathophysiology of this multisystem disorder, characterized by abnormal vascular response to placentation, is still unclear. Despite great polymorphism of the disease, the criteria for pre-eclampsia have not changed over the past decade (systolic blood pressure >140 mmHg or diastolic blood pressure ≥90 mmHg and 24-hour proteinuria ≥0.3 g). Clinical features and laboratory abnormalities define and determine the severity of pre-eclampsia. Delivery is the only curative treatment for pre-eclampsia. Multidisciplinary management, involving an obstetrician, anesthetist, and pediatrician, is carried out with consideration of the maternal risks due to continued pregnancy and the fetal risks associated with induced preterm delivery. Screening women at high risk and preventing recurrences are key issues in the management of pre-eclampsia.

Keywords: pre-eclampsia, epidemiology, pathophysiology, therapeutic management

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 


Other article by this author:

Short-term outcome of patients with preeclampsia

Koual M, Abbou H, Carbonnel M, Picone O, Ayoubi JM

Vascular Health and Risk Management 2013, 9:143-148

Published Date: 15 April 2013

Readers of this article also read:

Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy

Tanamachi Y, Saruwatari J, Noai M, Kamihashi R, Soraoka H, Yoshimori Y, Ogusu N, Oniki K, Yasui-Furukori N, Ishitsu T, Nakagawa K

Neuropsychiatric Disease and Treatment 2015, 11:1007-1014

Published Date: 7 April 2015

Fluorescent magnetic iron oxide nanoparticles for cardiac precursor cell selection from stromal vascular fraction and optimization for magnetic resonance imaging

Verma VK, Kamaraju SR, Kancherla R, Kona LK, Beevi SS, Debnath T, Usha SP, Vadapalli R, Arbab AS, Chelluri LK

International Journal of Nanomedicine 2015, 10:711-726

Published Date: 20 January 2015

What’s in the pipeline? Drugs in development for autism spectrum disorder

Sung M, Chin CH, Lim CG, Liew HSA, Lim CS, Kashala E, Weng SJ

Neuropsychiatric Disease and Treatment 2014, 10:371-381

Published Date: 20 February 2014

Update on pediatric dystonias: etiology, epidemiology, and management

Fernández-Alvarez E, Nardocci N

Degenerative Neurological and Neuromuscular Disease 2012, 2:29-41

Published Date: 12 April 2012

Detection of micrometastases in peripheral blood of non-small cell lung cancer with a refined immunomagnetic nanoparticle enrichment assay

Li Q, Qi H, Zhou HX, Deng CY, Zhu H, Li JF, Wang XL, Li FR

International Journal of Nanomedicine 2011, 6:2175-2181

Published Date: 29 September 2011

Diagnosis and management of pre-eclampsia: an update

Judi A Turner

International Journal of Women's Health 2010, 2:327-337

Published Date: 30 September 2010

Role of extended release quetiapine in the management of bipolar disorders

Rayan K Al Jurdi, Lena A Dixit, Martha Sajatovic

Neuropsychiatric Disease and Treatment 2010, 6:29-35

Published Date: 15 February 2010

Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers

André C Schmidt, Burkhard Flick, Elke Jahn, Peter Bramlage

Vascular Health and Risk Management 2008, 4:905-915

Published Date: 8 August 2008

Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors

Ziad F Bashshur, Abdallah M Terro, Christelle P El Haibi, Akaber M Halawi, Alexandre Schakal, Baha’ N Noureddin

Clinical Ophthalmology 2008, 2:269-274

Published Date: 6 June 2008